Calidi Biotherapeutics Inc (CLDI)
0.239
+0.01
(+5.43%)
USD |
NYAM |
May 08, 16:00
0.2299
-0.01
(-3.81%)
After-Hours: 07:57
Calidi Biotherapeutics Market Cap: 8.494M for May 8, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 08, 2024 | 8.494M |
| May 07, 2024 | 8.056M |
| May 06, 2024 | 7.463M |
| May 03, 2024 | 7.001M |
| May 02, 2024 | 7.143M |
| May 01, 2024 | 6.859M |
| April 30, 2024 | 6.930M |
| April 29, 2024 | 7.392M |
| April 26, 2024 | 5.711M |
| April 25, 2024 | 5.686M |
| April 24, 2024 | 5.612M |
| April 23, 2024 | 5.935M |
| April 22, 2024 | 5.544M |
| April 19, 2024 | 5.757M |
| April 18, 2024 | 5.686M |
| April 17, 2024 | 6.930M |
| April 16, 2024 | 7.360M |
| April 15, 2024 | 21.32M |
| April 12, 2024 | 24.69M |
| April 11, 2024 | 22.73M |
| April 10, 2024 | 20.87M |
| April 09, 2024 | 21.93M |
| April 08, 2024 | 13.50M |
| April 05, 2024 | 14.08M |
| April 04, 2024 | 15.06M |
| Date | Value |
|---|---|
| April 03, 2024 | 17.41M |
| April 02, 2024 | 17.73M |
| April 01, 2024 | 19.65M |
| March 28, 2024 | 20.08M |
| March 27, 2024 | 20.17M |
| March 26, 2024 | 20.26M |
| March 25, 2024 | 20.83M |
| March 22, 2024 | 20.61M |
| March 21, 2024 | 21.37M |
| March 20, 2024 | 23.21M |
| March 19, 2024 | 21.83M |
| March 18, 2024 | 21.32M |
| March 15, 2024 | 22.64M |
| March 14, 2024 | 21.64M |
| March 13, 2024 | 22.39M |
| March 12, 2024 | 23.92M |
| March 11, 2024 | 21.78M |
| March 08, 2024 | 22.42M |
| March 07, 2024 | 24.66M |
| March 06, 2024 | 24.11M |
| March 05, 2024 | 27.63M |
| March 04, 2024 | 21.91M |
| March 01, 2024 | 22.28M |
| February 29, 2024 | 21.19M |
| February 28, 2024 | 29.78M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.544M
Minimum
Apr 22 2024
175.94M
Maximum
Sep 13 2023
53.54M
Average
48.98M
Median
Jan 09 2024
Market Cap Benchmarks
| Minerva Neurosciences Inc | 17.55M |
| Viking Therapeutics Inc | 8.812B |
| Regenxbio Inc | 816.71M |
| CytomX Therapeutics Inc | 283.75M |
| Janux Therapeutics Inc | 2.860B |
Market Cap Related Metrics
| Price | 0.239 |
| Earnings Yield | -308.3% |